• sales@syndicatedanalytics.com
  • +1-213-316-7435

GCC Intravenous Solutions Market by Type (Partial Parenteral Nutrition and Total Parenteral Nutrition) by Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins and Amino Acids): Industry Analysis, Trends, Growth and Forecast 2022-2027



GCC Intravenous Solutions Market Overview:

The GCC intravenous solutions market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027. Intravenous (IV) solutions are supplemental fluids that contain electrolytes, medications, water, and sugar. These solutions are prescribed to patients as per their medical condition, age, and body size, to restore fluid volume and treat the electrolyte balance. IV solutions offer nutrients to patients diagnosed with diabetes, cancer, immune deficiencies, heart failure, and other related diseases. In recent years, these solutions have gained momentum across the GCC region as they provide a rapid onset of drug effect as compared to other drug delivery systems.

One of the primary factors driving the market is the rising prevalence of malnutrition across the GCC countries. Additionally, intravenous solutions have a faster response time and efficacy, thereby creating a positive market outlook. Other than this, the rising geriatric population is positively influencing the market growth. Besides this, there is a significant rise in the prevalence of chronic illnesses, such as cancer and the natality rate. In line with this, the increasing incidences of gastrointestinal disorders, such as obesity, AIDS, disorders, and diabetes in the region, have propelled the market growth. Furthermore, governments of numerous GCC countries, such as Saudi Arabia, Qatar, and Oman, are undertaking initiatives to provide enhanced healthcare facilities to their citizens, which is consequently increasing the demand for IV solutions across the region.  Other than these factors, key players are extensively investing in research and development (R&D) activities to introduce new IV solution products for various diseases and the treatment of dehydration. Furthermore, the sudden outbreak of the coronavirus disease (COVID-19) has tremendously escalated the demand for intravenous injections. This is creating lucrative growth opportunities for the key players. IV nutrition is a vital aspect of any treatment to assist patients meet their nutritional needs and heal faster. Moreover, IV solutions are widely adopted to improve skin conditions and treat migraines and hangovers. Other growth-inducing factors include, the launch of ready-to-use, portable product variants, introduction of premixed solutions to avoid packaging waste, and rising investments in the healthcare sector. 

Beginning with a regional overview, the report explores the dynamics that have a strong influence on the GCC intravenous solutions market and can also impact its future growth. Taking 2021 as the base year, the report covers historical market scenario from 2016-2021 and provides forecasts till 2027. This includes the study of value and volume trends and pricing history. Growth inducing factors, market restraints and recent developments have also been analysed in the report in order to provide a deeper knowledge about the industry. On a regional basis, the report examines the GCC intravenous solutions market in Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. For each of these regions, the report studies the GCC intravenous solutions market in detail for latest trends, outlook and opportunities.

The report analyses the competitive structure of the GCC intravenous solutions market industry and provides the profiles of major players operating in the market. The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the GCC intravenous solutions market industry along the parameters of the Porter’s Five Forces model. This model examines the degree of competition in the GCC intravenous solutions market industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the GCC intravenous solutions market industry. Furthermore, the value chain analysis of the GCC intravenous solutions market industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing, sales and distribution. 

GCC Intravenous Solutions Market Segment Insights:

The GCC intravenous solutions market has been analysed as followed:

By Type:

  • Partial Parenteral Nutrition
  • Total Parenteral Nutrition

By Nutrients:

  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids

By Country:

  • Saudi Arabia
  • UAE
  • Qatar
  • Oman
  • Kuwait
  • Bahrain

Country-wise, the market has been segmented into Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. Amongst these, Saudi Arabia represents the largest market, accounting for majority of the GCC region.

Competative Landscape: 

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Highlights of the GCC Intravenous Solutions Market Report:

  • Historical and current scenario
  • Trends and developments
  • Impact of COVID-19
  • Market forecast
  • Price analysis and forecast
  • Porter’s five forces analysis
  • SWOT analysis
  • Value chain analysis

Report Customisation:

The GCC intravenous solutions market report can be customised as per your requirements. You can get in touch with our analyst, who will make sure that the report suits your research needs

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    GCC Intravenous Solutions Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    Partial Parenteral Nutrition
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Total Parenteral Nutrition
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Nutrients
    7.1    Carbohydrates
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Salts and Electrolytes
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Minerals
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Vitamins
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Amino Acids
        7.5.1 Market Trends
        7.5.2 Market Forecast 
8    Market Breakup by Country
    8.1    Saudi Arabia
        8.1.1 Market Trends
        8.1.2 Market Breakup by Type
        8.1.3 Market Breakup by Nutrients
        8.1.4 Market Forecast
    8.2    UAE
        8.2.1 Market Trends
        8.2.2 Market Breakup by Type
        8.2.3 Market Breakup by Nutrients
        8.2.4 Market Forecast
    8.3    Qatar
        8.3.1 Market Trends
        8.3.2 Market Breakup by Type
        8.3.3 Market Breakup by Nutrients
        8.3.4 Market Forecast
    8.4    Oman
        8.4.1 Market Trends
        8.4.2 Market Breakup by Type
        8.4.3 Market Breakup by Nutrients
        8.4.4 Market Forecast
    8.5    Kuwait
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Bahrain
        8.6.1 Market Trends
        8.6.2 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Policy and Regulatory Landscape
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players

List of Figures

Figure 1: GCC: Intravenous Solutions Market: Major Drivers and Challenges
Figure 2: GCC: Intravenous Solutions Market: Sales Value (in Million US$), 2016-2021
Figure 3: GCC: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: GCC: Intravenous Solutions Market: Breakup by Type (in %), 2021
Figure 5: GCC: Intravenous Solutions Market: Breakup by Nutrients (in %), 2021
Figure 6: GCC: Intravenous Solutions Market: Breakup by Country (in %), 2021
Figure 7: GCC: Intravenous Solutions (Partial Parenteral Nutrition) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: GCC: Intravenous Solutions (Partial Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: GCC: Intravenous Solutions (Total Parenteral Nutrition) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: GCC: Intravenous Solutions (Total Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: GCC: Intravenous Solutions (Carbohydrates) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: GCC: Intravenous Solutions (Carbohydrates) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: GCC: Intravenous Solutions (Salts and Electrolytes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: GCC: Intravenous Solutions (Salts and Electrolytes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: GCC: Intravenous Solutions (Minerals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: GCC: Intravenous Solutions (Minerals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: GCC: Intravenous Solutions (Vitamins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: GCC: Intravenous Solutions (Vitamins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: GCC: Intravenous Solutions (Amino Acids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: GCC: Intravenous Solutions (Amino Acids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Saudi Arabia: Intravenous Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Saudi Arabia: Intravenous Solutions Market: Breakup by Type (in %), 2021
Figure 23: Saudi Arabia: Intravenous Solutions Market: Breakup by Nutrients (in %), 2021
Figure 24: Saudi Arabia: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: UAE: Intravenous Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: UAE: Intravenous Solutions Market: Breakup by Type (in %), 2021
Figure 27: UAE: Intravenous Solutions Market: Breakup by Nutrients (in %), 2021
Figure 28: UAE: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Qatar: Intravenous Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Qatar: Intravenous Solutions Market: Breakup by Type (in %), 2021
Figure 31: Qatar: Intravenous Solutions Market: Breakup by Nutrients (in %), 2021
Figure 32: Qatar: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Oman: Intravenous Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Oman: Intravenous Solutions Market: Breakup by Type (in %), 2021
Figure 35: Oman: Intravenous Solutions Market: Breakup by Nutrients (in %), 2021
Figure 36: Oman: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Kuwait: Intravenous Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Kuwait: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Bahrain: Intravenous Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Bahrain: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: GCC: Intravenous Solutions Industry: SWOT Analysis
Figure 42: GCC: Intravenous Solutions Industry: Value Chain Analysis
Figure 43: GCC: Intravenous Solutions Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: GCC: Intravenous Solutions Market: Key Industry Highlights, 2021 and 2027
Table 2: GCC: Intravenous Solutions Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: GCC: Intravenous Solutions Market Forecast: Breakup by Nutrients (in Million US$), 2022-2027
Table 4: GCC: Intravenous Solutions Market Forecast: Breakup by Country (in Million US$), 2022-2027
Table 5: GCC: Intravenous Solutions Market: Competitive Structure
Table 6: GCC: Intravenous Solutions Market: Key Players

Special Prices


    Syndicated Analytics provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations

  • For more information, feel free to contact us.





Related Reports

Saudi Arabia Health Insurance Market by Type (Individual and Group) by Service Provider (Public and Private): Industry Analysis, Trends, Growth and Forecast 2022-2027

The Saudi Arabia health insurance market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027.

Saudi Arabia In-Vitro Diagnostics (IVD) Market by Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases and Others) End-User (Hospital-Based Centres, Diagnostics Chains, Standalone Centres and Others): Industry Analysis, Trends, Growth and Forecast 2022-2027

The Saudi Arabia in-vitro diagnostics (ivd) market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027. 

UAE mHealth Market by Components, by Service Type, by Stakeholders and by Application: Industry Analysis, Trends, Growth and Forecast 2022-2027

The UAE mhealth market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027.

UAE In-Vitro Diagnostics Devices Market by Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases and Others) by End-User (Hospital-Based Centres, Diagnostics Chains, Standalone Centres and Others): Industry Analysis, Trends, Growth and Forecast 2022-2027

The UAE in vitro diagnostics devices market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027.

Saudi Arabia Diabetes Market: Industry Analysis, Trends, Growth and Forecast 2022-2027

The Saudi Arabia diabetes market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027.